ACTRN12624000456550
Not yet recruiting
未知
A Randomised Controlled Trial of the Efficacy of Internet-Based Cognitive Behaviour Therapy plus messaging support for managing child and adolescent anxiety in regional communities
niversity of Southern Queensland0 sites150 target enrollmentApril 15, 2024
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversity of Southern Queensland
- Enrollment
- 150
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Children and adolescents will be invited to participate in the study if they meet the following criteria at initial registration for the Momentum platform;
- •(1\) if they present with elevated levels of anxiety on the Spence Children’s Anxiety Scale (equal or greater than 84th percentile or T\-score of 60\);
- •(2\) are residents of regional/rural areas (as classified by areas 2\-7 of the Modified Monash Model, identified via postcode);
- •(3\) do not demonstrate clinically interfering depression levels on the Centre for Epidemiological Studies Depression Scale for Children. Clinically interfering levels are defined as meeting the 'elevated' cut\-off on this scale AND rating the degree of interference from the depression at a minimum of 5 or higher on an 8\-point scale;
- •(4\) have access to the Momentum online platform via a computer or mobile device with an Australian IP address;
- •(5\) aged 7\-17 years;
- •Additional inclusion criteria (ascertained via interview):
- •(1\) a primary diagnosis of social anxiety disorder (SAD), generalised anxiety disorder (GAD), separation anxiety (SEP), or specific phobia (SP) on the Anxiety Disorders Interview Schedule for Children – Child and Parent version (ADIS\-C/P; Silverman and Albano, 1996\);
- •(2\) willingness to be randomised to one of the two conditions.
- •Children and adolescents with a primary diagnosis of obsessive\-compulsive disorder (OCD), posttraumatic disorder (PTSD) or panic disorder (PD) will not be eligible for participation. However, these diagnoses will be permitted if secondary. Participants with secondary mood disorders will be included, provided that their mood disturbance had a clinician severity rating (CSR) of \<5 on the ADIS\-C/P.
Exclusion Criteria
- •Children and adolescents with current suicidal ideation, self\-harm tendencies, substance abuse issues, significant behavioural disorders, pervasive developmental disorders, learning disorders, or those currently receiving professional help, as well as those who initiated or altered medication for anxiety or sleep within the six weeks leading up to the baseline assessment, will be excluded from the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
Tenecteplase versus Alteplase before Endovascular Therapy for Ischemic Stroke (EXTEND-IA TNK)ACTRN12615000220561euroscience Trials Australia64
Not yet recruiting
Phase 2
Effectiveness of Salbutamol in treatment of TTNB- A RCT STUDYCTRI/2023/09/057567Department of pediatrics INHS ASVINI
Completed
Not Applicable
Randomized controlled trial on the efficacy of the prolonged exposure therapy for PTSDJPRN-UMIN000001183ational Institute of Mental Health, National Center of Neurology and Psychiatry40
Completed
Not Applicable
Randomized controlled trial on the efficacy of the Trauma-Focused Cognitive Behavioral Therapy for children with posttraumatic stress disorderJPRN-UMIN000010699Hyogo Earthquake Memorial 21th Century Research Institute30
Not yet recruiting
Phase 3
A Study To See The Effect Of Aragvadha Ointment In Dushta Vrana (Infected Wound) With Special Reference To Microbial LoadHealth Condition 1: T148- Other injury of unspecified body regionCTRI/2024/05/067854Dr Akanksha Sunil Akulwar